NMN and Hair Growth: What the Science Says

NMN Hair Growth has become a frequent search query among people looking for science-backed ways to address thinning hair. The idea is plausible: nicotinamide mononucleotide (NMN) boosts NAD+, a coenzyme that declines with age and plays a role in cellular energy and repair. But plausible ideas need evidence. Here is what the human research actually shows — and what it does not.

The Evidence Base

As of mid-2026, no published randomized controlled trial (RCT) has tested NMN specifically for hair growth or hair loss in humans. The existing human studies on NMN focus on metabolic health, exercise performance, and aging biomarkers — not dermatology. This is a critical gap that anyone searching for NMN Hair Growth should understand upfront.

What we do have are six human studies that establish NMN's safety profile and its effects on NAD+ metabolism, muscle function, and related biomarkers. Yoshino et al. (2021) conducted a placebo-controlled RCT in prediabetic women, showing that NMN increased muscle insulin sensitivity over 10 weeks. Igarashi et al. (2022) ran a 12-week RCT in healthy older men and found that NMN elevated blood NAD+ levels and altered muscle function markers. Irie et al. (2020) performed an open-label study in healthy Japanese men, confirming that oral NMN raises blood NAD+ metabolites. Liao et al. (2021) tested NMN in amateur runners and reported improved aerobic capacity. Niu et al. (2023) conducted a short-term trial in middle-aged adults and observed changes in serum metabolism, gut microbiota, and telomere length — a marker of cellular aging.

None of these studies measured hair density, follicle count, or any dermatological outcome. The connection between NMN and hair growth is therefore indirect: it rests on mechanistic reasoning from NAD+ biology, not on clinical data for androgenetic alopecia, telogen effluvium, or any other hair-loss condition.

Study	Design	Population	Duration	Dose	Primary Outcome	Hair-Related Data
Yoshino et al. (2021)	RCT, double-blind	Prediabetic women	10 weeks	250 mg/day	Muscle insulin sensitivity	None
Igarashi et al. (2022)	RCT, double-blind	Healthy older men	12 weeks	250 mg/day	Blood NAD+ levels, muscle function	None
Irie et al. (2020)	Open-label	Healthy Japanese men	Single dose to 12 weeks	Up to 500 mg/day	Plasma NMN and metabolite levels	None
Liao et al. (2021)	RCT, double-blind	Amateur runners	6 weeks	300–1200 mg/day	Aerobic capacity (ventilatory threshold)	None
Niu et al. (2023)	RCT, single-blind	Pre-aging adults	8 weeks	300 mg/day	Serum metabolism, telomere length	None

The table above summarizes every human NMN trial provided in the reference set. The "Hair-Related Data" column is uniformly blank because no investigator asked the question. This is not a criticism of the research — it simply means the hypothesis that NMN promotes hair growth has not been tested in humans.

The Mechanism

Why, then, does the NMN Hair Growth conversation exist at all? The reasoning starts with NAD+, the molecule NMN is designed to replenish.

NAD+ and the Hair Follicle

Hair follicles are among the most metabolically active tissues in the body. The anagen (growth) phase demands high levels of ATP, which is generated primarily through mitochondrial oxidative phosphorylation. NAD+ is an essential cofactor for enzymes involved in both glycolysis and mitochondrial respiration. Gomes et al. (2013) demonstrated that declining NAD+ during aging disrupts nuclear-mitochondrial communication, creating a "pseudohypoxic" state in which cells behave as if oxygen is low even when it is not. This state impairs mitochondrial function and may accelerate the miniaturization of hair follicles — a hallmark of pattern hair loss.

Restoring NAD+ through NMN supplementation could, in theory, improve the energy status of dermal papilla cells and keratinocytes, potentially prolonging anagen or delaying follicle senescence. But this is a chain of inferences. No human study has shown that NMN increases ATP production in hair follicles, shifts follicles from telogen to anagen, or reduces dihydrotestosterone (DHT) sensitivity in the scalp.

Sirtuins and Cellular Repair

NAD+ also activates sirtuins, a family of deacetylase enzymes involved in DNA repair, stress resistance, and mitochondrial biogenesis. Sirtuin activation has been linked to improved tissue maintenance in animal models. Niu et al. (2023) reported that short-term NMN supplementation was associated with increased telomere length in a pre-aging cohort — a finding that suggests systemic cellular repair effects. Whether these effects extend to the hair follicle stem-cell niche is unknown in humans.

Animal studies (not cited here because they fall outside the provided reference set) have shown that NAD+ precursors can influence hair pigmentation and follicle cycling in mice. These data are suggestive but not translatable without human validation. The gap between mouse dermal biology and human androgenetic alopecia is substantial.

What the Evidence Does Not Show

It is worth being explicit about the limits. No study in the provided set — or in the broader peer-reviewed literature as of this writing — has established that NMN:

• Increases hair count or hair diameter in humans
• Prevents or treats androgenetic alopecia, telogen effluvium, or alopecia areata
• Outperforms minoxidil, finasteride, or low-level laser therapy
• Works topically when applied to the scalp
• Is safe at doses above 1200 mg/day for extended periods

The highest-quality evidence for NMN in humans supports metabolic and muscular benefits at doses between 250 mg and 1200 mg per day. Igarashi et al. (2022) and Yoshino et al. (2021) both used 250 mg/day with measurable physiological effects. Liao et al. (2021) tested a dose-response range up to 1200 mg/day and found aerobic benefits at the higher end, but with diminishing returns and no additional safety signals in the short term. These data inform general NMN dosing but do not specify a hair-growth protocol.

Anyone experiencing significant hair loss should consult a dermatologist. Pattern hair loss has well-established pathophysiology involving DHT, follicle miniaturization, and inflammation. NMN does not address DHT, and there is no evidence it acts as an anti-inflammatory in the scalp.

Who Benefits Most

Given the current evidence, the strongest case for trying NMN in the context of hair health applies to specific populations — not as a hair-loss treatment, but as part of a broader cellular health strategy.

Adults over 40 with age-related thinning. NAD+ declines measurably with age, and Gomes et al. (2013) linked this decline to tissue-level dysfunction. Niu et al. (2023) showed that NMN can shift biomarkers associated with aging in a pre-aging cohort. For individuals whose hair thinning coincides with other signs of cellular aging (fatigue, slower recovery, metabolic drift), NMN may be a rational adjunct. It is not a replacement for proven therapies.

People already optimizing metabolic health. Yoshino et al. (2021) demonstrated improved muscle insulin sensitivity with NMN. If you are already addressing insulin resistance, exercise capacity, and mitochondrial health, NMN fits logically into that stack. Hair benefits, if they occur, would likely be secondary and gradual.

Those with realistic expectations and patience. Hair follicle cycling operates on a timeline of months. Even interventions with strong evidence, like minoxidil, require 3–6 months for visible results. With NMN, the timeline is undefined because the data do not exist. Anyone trying NMN for hair should commit to at least 6 months before evaluating results, and should track outcomes with standardized photography rather than subjective impression.

For readers interested in how NAD+ depletion progresses across the lifespan, see our breakdown of NAD+ Decline by Age. If you are evaluating supplements more broadly for appearance-related concerns, our guide to Supplements for Hair, Skin & Nails covers nutrients with stronger direct evidence.

Practical Takeaways

• There is no human clinical evidence that NMN promotes hair growth — the hypothesis is mechanistically plausible but untested.
• Human RCTs show that NMN safely raises NAD+ levels and improves metabolic and exercise outcomes at doses of 250–1200 mg/day.
• If you try NMN for hair health, commit to at least 6 months and use objective tracking; subjective assessment is unreliable for slow-changing outcomes.
• Do not discontinue proven hair-loss treatments (e.g., minoxidil, finasteride) in favor of NMN; the two are not interchangeable.
• Consult a dermatologist for persistent or progressive hair loss; NMN is a wellness supplement, not a medical therapy.
• Choose a reputable NMN product with third-party purity testing. For example, Bio:sudo NMN 1000mg provides a single-tablet dose that aligns with the upper range studied in human trials, though individual needs vary.

Bottom Line

The NMN Hair Growth question is premature: the science has not yet asked it in a controlled human study. What we know is that NMN reliably raises NAD+, that NAD+ supports cellular energy and repair, and that hair follicles are energy-intensive organs. The bridge between those facts and a proven hair-growth effect has not been built. For now, NMN is best viewed as a general cellular health supplement with theoretical, unvalidated relevance to hair biology — not as a hair-loss solution.

References

1. Yoshino M, et al. "Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women." Science. 2021;372(6547):1224–1229. [Source]
2. Igarashi M, et al. "Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men." npj Aging. 2022;8(1):5. [Source]
3. Irie J, et al. "Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men." Endocrine Journal. 2020;67(2):153–160. [Source]
4. Liao B, et al. "Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study." Journal of the International Society of Sports Nutrition. 2021;18(1):54. [Source]
5. Gomes AP, et al. "Declining NAD+ induces a pseudohypoxic state disrupting nuclear-mitochondrial communication during aging." Cell. 2013;155(7):1624–1638. [Source]
6. Niu KM, et al. "The impacts of short-term NMN supplementation on serum metabolism, fecal microbiota, and telomere length in pre-aging phase." Nutrients. 2023;15(3):755. [Source]

---

---